Review |
Department of Pediatrics, University of Texas - Houston Medical School, Houston, TX, USA; Division of Epidemiology, University of Texas School of Public Health, Houston, TX, USA
Because of the long-term consequences of pelvic inflammatory disease (PID), the cost-effectiveness of Chlamydia trachomatis screening depends in part on the incidence of PID in untreated, chlamydia-infected women. The aim of this study was to evaluate the original research assessing the incidence of PID following C. trachomatis infection. We conducted a thorough search of the literature and selected all available prospective cohort studies. Six studies had original data: the incidence of PID varied from 0% (97.5% confidence interval [CI] 0–12%) during one year of follow-up of 30 women to 30% (95% CI 12–54%) during 50 days of follow-up of 20 women. Studies that included asymptomatic women in other settings reported a lower incidence than those that evaluated women in sexually transmitted disease clinics. In conclusion, no study was of a size or quality to answer our research question definitively. Investigators and clinicians planning chlamydia-screening programmes need to be cognizant of the inconclusive incidence data.
Key Words: CHLAMYDIA TRACHOMATIS PELVIC INFLAMMATORY DISEASE EPIDEMIOLOGY
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Aghaizu, H. Atherton, H. Mallinson, I. Simms, S. Kerry, P. Oakeshott, and P. E Hay Incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis Int J STD AIDS, April 1, 2008; 19(4): 283 - 283. [Full Text] [PDF] |
||||
![]() |
I Simms and P Horner Has the incidence of pelvic inflammatory disease following chlamydial infection been overestimated? Int J STD AIDS, April 1, 2008; 19(4): 285 - 286. [Full Text] [PDF] |
||||